Ajax loader
By using our website, you agree to our use of cookies as described in Cookie Policy
 For more images, please select "images" in the filters.
A study of a pilot sensory history questionnaire using contrasting groups
PDF
AIDS, it's big business!; Amgen, AIDS profiteer
PDF
Expression from retroviral vectors in murine hematopoietic stem cells and embryonic cell lines
PDF
Modulation of T cell responses by extracellular nucleotides
PDF
Cell and gene therapy in the murine model of adenosine deaminase deficiency
PDF
Linkers in Recombinant Fusion proteins
PDF
The experiences of African American graduate students: a cultural transition
PDF
Pdf
Evaluating novel chemotherapeutic strategies in colorectal and gastric cancer: the role of histone deacetylase inhibitors and human epidermal receptor family inhibitors
As the CEO goes, so goes the corporate culture: The evolving relationship between the chief executive officer and the public relations professional
PDF
PDF
Photocontrol of protein conformation and enzyme activity in the presence of light-responsive surfactants
PDF
US biosimilar market entry and uptake: US commercial payer preferences in access decision making
PDF
Regulatory dissonance in the global development of drug therapies: a case study of drug development in postmenopausal osteoporosis
PDF
Interorganizational knowledge networks: the case of the biotechnology industry
PDF
Regulatory team development in post-merger integration: a survey of views from medical product companies
PDF
Proinsulin-transferrin recombinant fusion protein: mechanism of activation and potential application in diabetes treatment
PDF
Systems pharmacology for acute myeloid leukemia and feedback control pharmacodynamic models
PDF
one-2018027-i019~01
one-2018027-i019~02
AIDS, it's big business!; Amgen, AIDS profiteer
Amgen Building 92, Thousand Oaks, Calif., 2004
Amgen Building 92, Thousand Oaks, Calif., 2004
Amgen Building 92, Thousand Oaks, Calif., 2004
Amgen Building 92, Thousand Oaks, Calif., 2004
of 3